title: Horizontal melanonychia.
authors.affiliation: Marmara University School of Medicine, Department of Dermatology, Istanbul, Turkey. Electronic address: asalmanitf@gmail.com.
authors.forename: A
authors.initials: A
authors.lastname: Salman
authors.affiliation: Marmara University School of Medicine, Department of Hematology, Istanbul, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Eser
authors.affiliation: Marmara University School of Medicine, Department of Hematology, Istanbul, Turkey.
authors.forename: I
authors.initials: I
authors.lastname: Kaygusuz Atagunduz
authors.affiliation: Marmara University School of Medicine, Department of Dermatology, Istanbul, Turkey.
authors.forename: T
authors.initials: T
authors.lastname: Ergun
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D000068877:Imatinib Mesylate / Q000009:adverse effects* / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D008548:Melanosis / Q000139:chemically induced* / Q000175:diagnosis; D009260:Nail Diseases / Q000139:chemically induced* / Q000175:diagnosis; D009264:Nails, Malformed / Q000139:chemically induced* / Q000175:diagnosis; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate